4.2 Letter

Empirical Research on the Ethics of Genomic Research

Journal

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 161, Issue 8, Pages 2099-2101

Publisher

WILEY
DOI: 10.1002/ajmg.a.36067

Keywords

-

Funding

  1. Wellcome Trust Funding Source: Medline

Ask authors/readers for more resources

(c) 2013 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY

Thomas W. Laver, Matthew N. Wakeling, Olivia Knox, Kevin Colclough, Caroline F. Wright, Sian Ellard, Andrew T. Hattersley, Michael N. Weedon, Kashyap A. Patel

Summary: This study found no evidence to support BLK, KLF11, and PAX4 as causes of MODY. These genes should not be included in genetic testing for MODY.

DIABETES (2022)

Article Genetics & Heredity

Assessing the clinical utility of protein structural analysis in genomic variant classification: experiences from a diagnostic laboratory

Richard C. Caswell, Adam C. Gunning, Martina M. Owens, Sian Ellard, Caroline F. Wright

Summary: The study investigated the number of variants of uncertain significance (VUS) evaluated using protein structural analysis in a UK genomic medicine diagnostic laboratory over a 5-year period. Evidence from protein structural analysis helped to reclassify a significant number of VUS as pathogenic or likely pathogenic, highlighting the utility of this approach in variant classification.

GENOME MEDICINE (2022)

Article Genetics & Heredity

Recommendations for clinical interpretation of variants found in non-coding regions of the genome

Jamie M. Ellingford, Joo Wook Ahn, Richard D. Bagnall, Diana Baralle, Stephanie Barton, Chris Campbell, Kate Downes, Sian Ellard, Celia Duff-Farrier, David R. FitzPatrick, John M. Greally, Jodie Ingles, Neesha Krishnan, Jenny Lord, Hilary C. Martin, William G. Newman, Anne O'Donnell-Luria, Simon C. Ramsden, Heidi L. Rehm, Ebony Richardson, Moriel Singer-Berk, Jenny C. Taylor, Maggie Williams, Jordan C. Wood, Caroline F. Wright, Steven M. Harrison, Nicola Whiffin

Summary: This article discusses genetic variants in non-coding regions and proposes guidelines for defining and interpreting these variants. The aim of these guidelines is to increase the number and range of non-coding region variants that can be clinically interpreted, leading to new diagnoses and the discovery of novel disease mechanisms.

GENOME MEDICINE (2022)

Review Genetics & Heredity

Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts

Rebecca Kingdom, Caroline F. Wright

Summary: The same genetic variant can cause a range of phenotypes, displaying incomplete penetrance or variable expressivity, influenced by various factors. Investigating the penetrance and expressivity of genetic variants is important for clinical classification and genetic counseling. Population cohort data can help redefine the understanding of these variants. Researching the causes of incomplete penetrance and variable expressivity in rare diseases is critical for our understanding.

FRONTIERS IN GENETICS (2022)

Article Genetics & Heredity

Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts

Uyenlinh L. Mirshahi, Kevin Colclough, Caroline F. Wright, Andrew R. Wood, Robin N. Beaumont, Jessica Tyrrell, Thomas W. Laver, Richard Stahl, Alicia Golden, Jessica M. Goehringer, Timothy F. Frayling, Andrew T. Hattersley, David J. Carey, Michael N. Weedon, Kashyap A. Patel

Summary: The prevalence and penetrance of pathogenic variants in HNF1A, HNF4A, and GCK, which account for a significant proportion of monogenic diabetes, were comprehensively assessed in this study. The results showed that these variants are not ultra-rare in the population, and their penetrance varies depending on different settings and genetic factors. GCK variants have near-complete penetrance in all settings, making it a potential candidate for genetic testing and counseling.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Article Biochemistry & Molecular Biology

The genetic counsellor role in the United Kingdom Position on behalf of the Association of Genetic Nurses and Counsellors (AGNC), Endorsed by the Genetic Counsellor Registration Board (GCRB) and Academy for Healthcare Science (AHCS)

Anna Middleton, Nicola Taverner, Natalie Moreton, Roberta Rizzo, Catherine Houghton, Catherine Watt, Esther Horton, Sara Levene, Phil Leonard, Athalie Melville, Somya Ellis, Vishakha Tripathi, Christine Patch, Elaine Jenkins

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

Scope of professional roles for genetic counsellors and clinical geneticists in the United Kingdom

Anna Middleton, Nicola Taverner, Catherine Houghton, Sarah Smithson, Meena Balasubramanian, Frances Elmslie

Summary: This document, written by professional bodies in the UK, aims to support the multidisciplinary working of genetic counsellors and clinical geneticists. It provides a quick-reference format that highlights shared practice areas and distinctions between different role profiles.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Genetics & Heredity

Gain-of-function mutations in KCNK3 cause a developmental disorder with sleep apnea

Janina Sormann, Marcus Schewe, Peter Proks, Thibault Jouen-Tachoire, Shanlin Rao, Elena B. Riel, Katherine E. Agre, Amber Begtrup, John Dean, Maria Descartes, Jan Fischer, Alice Gardham, Carrie Lahner, Paul R. Mark, Srikanth Muppidi, Pavel N. Pichurin, Joseph Porrmann, Jens Schallner, Kirstin Smith, Volker Straub, Pradeep Vasudevan, Rebecca Willaert, Elisabeth P. Carpenter, Karin E. J. Rodstrom, Michael G. Hahn, Thomas Mueller, Thomas Baukrowitz, Matthew E. Hurles, Caroline F. Wright, Stephen J. Tucker

Summary: Sleep apnea, a common disorder with significant public health burden, has been associated with rare gain-of-function mutations in the KCNK3 gene, highlighting a new role for TASK-1 K+ channels and presenting possible therapeutic strategies.

NATURE GENETICS (2022)

Correction Multidisciplinary Sciences

Clinically-relevant postzygotic mosaicism in parents and children with developmental disorders in trio exome sequencing data (vol 10, 2985, 2019)

C. F. Wright, E. Prigmore, D. Rajan, J. Handsaker, J. McRae, J. Kaplanis, T. W. Fitzgerald, D. R. FitzPatrick, H. V. Firth, M. E. Hurles

NATURE COMMUNICATIONS (2022)

Editorial Material Genetics & Heredity

Importance of adopting standardized MANE transcripts in clinical reporting

Caroline F. Wright, David R. FitzPatrick, James S. Ware, Heidi L. Rehm, Helen V. Firth

GENETICS IN MEDICINE (2023)

Editorial Material Ethics

What Difference Can Public Engagement in Genome Editing Make, and for Whom?

Richard Milne, Ugbaad Aidid, Jerome Atutornu, Tuba Bircan, Daniela Boraschi, Alessia Costa, Sasha Henriques, Christine Patch, Anna Middleton

AMERICAN JOURNAL OF BIOETHICS (2023)

Article Genetics & Heredity

Evaluation of in silico pathogenicity prediction tools for the classification of small in-frame indels

S. Cannon, M. Williams, A. C. Gunning, C. F. Wright

Summary: This study evaluated nine tools for predicting the pathogenicity of in-frame insertions/deletions (indels) and found that they perform well enough to aid in clinical variant classification, similar to missense prediction tools.

BMC MEDICAL GENOMICS (2023)

Article Medicine, General & Internal

Genomic Diagnosis of Rare Pediatric Disease in the United Kingdom and Ireland

Caroline F. Wright, Patrick Campbell, Ruth Y. Eberhardt, Stuart Aitken, Daniel Perrett, Simon Brent, Petr Danecek, Eugene J. Gardner, V. Kartik Chundru, Sarah J. Lindsay, Katrina Andrews, Juliet Hampstead, Joanna Kaplanis, Kaitlin E. Samocha, Anna Middleton, Julia Foreman, Rachel J. Hobson, Michael J. Parker, Hilary C. Martin, David R. FitzPatrick, Matthew E. Hurles, Helen V. Firth

Summary: This study conducted a large-scale sequencing study and discovered novel genetic causes in severe, probably monogenic, difficult-to-diagnose developmental disorders in the United Kingdom and Ireland. The results showed that multimodal analysis of genomewide data had good diagnostic power for these patients.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Genetics & Heredity

The legacy of language: What we say, and what people hear, when we talk about genomics

Anna Middleton, Alessia Costa, Richard Milne, Christine Patch, Lauren Robarts, Ben Tomlin, Mark Danson, Sasha Henriques, Jerome Atutornu, Ugbaad Aidid, Daniela Boraschi, Catherine Galloway, Keith Yazmir, Sachi Pettit, Tegan Harcourt, Alannah Connolly, Amanda Li, Jacob Cala, Shelby Lake, Julian Borra, Vivienne Parry

Summary: Our research explores the difference between what we say and what people hear when providing information about genetics. We find that starting conversations by emphasizing the potential benefits of genomics may lead to skepticism and cynicism. Instead, acknowledging the public's questions and concerns about genomics before discussing the science can lead to more productive conversations.

HUMAN GENETICS AND GENOMICS ADVANCES (2023)

Letter Health Care Sciences & Services

A public backlash towards genomics is a risk all of us working in genomics must share

Anna Middleton, Vivienne Parry, Julian Borra, Kate Orviss

LANCET REGIONAL HEALTH-EUROPE (2022)

No Data Available